Alzheimer’s Drug PRI-002 Receives EMA Approval for Phase II Trial
The Alzheimer’s drug candidate PRI-002 is entering the next clinical trial phase: the European Medicines Agency (EMA) has granted approval to conduct a phase ...
Page Content
-
-
Brain Research Katrin Amunts Awarded the International Justine and Yves Sergent Award
Helmholtz Information congratulates: Prof. Katrin Amunts has been honored with the 2023 International Justine and Yves Sergent Award. The award is given to internationally ...
-
New AI Tool for Brain Tumor Diagnostics
A team at the Research Centre Jülich from the Helmholtz Research Field Information has developed a deep learning algorithm that can automatically detect and ...
-
New SMART-Lab for Tumour Research
The Research Centre Jülich is intensifying its collaboration with Georgian universities through the establishment of a new SMART-Lab for Biomedical Imaging. Supported by the ...
-
Human Brain Project celebrates successful completion
The EU-funded Human Brain Project (HBP) reached its conclusion in September and recently celebrated this achievement with a scientific symposium at the Jülich Research ...
-
Human Brain Project study offers insights into neurotransmitter receptor organisation
Researchers from the Human Brain Project (HBP) in the Helmholtz Research Field Information have conducted a comprehensive study examining the distribution of receptors in ...
-
A platform for biomarkers
The Ministry of Culture and Science (MKW) of the state of North Rhine-Westphalia is funding a collaborative platform between Forschungszentrum Jülich and the university ...
-
Sleep deprivation makes brain look old
Just sleeping one night without sleep is all it takes: In a new study, a team of scientists from Denmark, Switzerland, the United States, ...
-
Structural change of the cerebral cortex and pathological diagnoses
Researchers at the Jülich Institute of Neuroscience and Medicine from the Helmholtz Research Field Information have been able to show that the brain exhibits ...
-
Parkinson’s research: lipids influence the structure of protein clumps
After Alzheimer’s disease, Parkinson’s is the most common neurodegenerative disease worldwide. Up to 400,000 people suffer from it in Germany alone. Defective alpha-synuclein proteins ...